PSIAC
Sad Pill Bild Bildrechte: © spinetta / Fotolia

Oops!

Sie verwenden eine veraltete Version Ihres Internetbrowsers und können nicht auf die Inhalte der Seite zugreifen.
Bitte aktualisieren Sie Ihre Browserversion.

PSIAC

Literaturverzeichnis

Erweiterte Suche
Faruquee CF. Pak J Pharm Sci. Apr 2010; 23(2): 143-8 Pubmed [5188]
Fasipe OJ. IBRO Rep. Jan 2019; 6: 95-110 Pubmed, Volltext, DOI [9875]
Faskowitz AJ. Cell Mol Neurobiol. May 2013; 33(4): 537-42 Pubmed [12986]
Fattinger K. Eur J Clin Pharmacol. Feb 2002; 57(12): 863-7 Pubmed [11826]
Faucette SR. Drug Metab Dispos. Mar 2004; 32(3): 348-58 Pubmed [425]
Faucette SR. Drug Metab Dispos. Oct 2000; 28(10): 1222-30 Pubmed [67]
Fauchier JP. Arch Mal Coeur Vaiss. May 1993; 86(5 Suppl): 757-67 Pubmed [8804]
Fava M. Int Clin Psychopharmacol. Nov 2018; 33(6): 312-321 Pubmed, Volltext, DOI [10147]
Favale E. Seizure. Jul 2003; 12(5): 316-8 Pubmed [10623]
Fawcett RG. Erythema multiforme major in a patient treated with carbamazepine. J Clin Psychiatry (1887) 48, 416-17 [845]
Fayssoil A. Ann Cardiol Angeiol (Paris). Jun 2011; 60(3): 165-8 Pubmed [3554]
Fazel Y. Expert Opin Drug Saf. Aug 2015; 14(8): 1317-26 Pubmed [6962]
Fazzi P. Am J Respir Med. Jan 2003; 2(4): 311-20 Pubmed [8875]
FDA Drug Safety Communication: Revised recommendations for cardiovascular monitoring and use of multiple sclerosis drug Gilenya (fingolimod). U.S. Food and Drug Administration (FDA). Stand Dec 2017. https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-revised-recommendations-cardiovascular-monitoring-and-use-multiple [10020]
FDA Stand: 17.02.2016 [25]
Feder A. Am J Psychiatry. Feb 2021; 178(2): 193-202 Pubmed [12416]
Feder. J Clin Psychiatry (1991) 52, 163-164 [1349]
Federico S. Clin Pharmacokinet. Jan 2006; 45(2): 169-75 Pubmed [5671]
Fedgchin M. Int J Neuropsychopharmacol. Oct 2019; 22(10): 616-630 Pubmed [12068]
Fee JPH, et al. Clin Pharmacol Ther (1987) 41, 80-4 [1862]
Feely J. N Engl J Med. Mar 1981; 304(12): 692-5 Pubmed [4152]
Feierman DE. Drug Metab Dispos. Sep 1996; 24(9): 932-9 Pubmed [4702]
Feigenson JS. Neurology. May 1976; 26(5): 430-3 Pubmed [10435]
Feiger AD. CNS Spectr. Jan 2009; 14(1): 41-50 Pubmed [12605]
Feighner JP. J Clin Psychiatry. Jun 1990; 51(6): 222-5 Pubmed [1393]
Fein S. Am J Psychiatry. Feb 1988; 145(2): 249-50 Pubmed [1741]
Feinberg SS. J Clin Psychiatry. Nov 2004; 65(11): 1520-4 Pubmed [2368]
Fekete S. Pharmacopsychiatry. May 2021; 54(3): 117-125 Pubmed [10907]
Feld JJ. Liver Int. Jan 2017; 37(1): 5-18 Pubmed, Volltext, DOI [7904]
Feldman et al. J Pharm Clin (1995) 14, 296-297 [1489]
Feldman M. Int J Neurosci. Jun 2021; : 1-12 Pubmed [12193]
Feldman RG. JAMA. Dec 1976; 236(23): 2603 Pubmed [2191]
Feldman SA. Br Med J. May 1970; 2(5705): 336-8 Pubmed, Volltext [1284]
Fell et al. Eur J Clin Pharmacol (1973) 5, 166-173 [1840]
Felmlee MA. AAPS J. Jan 2021; 23(1): 22 Pubmed [12698]
Felthous AR. Pharmacotherapy. Apr 2010; 30(4): 145e-50e Pubmed [12945]
Fendrich Z. Cas Lek Cesk. Jul 2000; 139(14): 440-4 Pubmed [8564]
Feng HP. Antimicrob Agents Chemother. Feb 2019 Pubmed [6524]
Feng HP. Clin Pharmacol Drug Dev. Jun 2019 Pubmed [7883]
Feng HP. Clin Transl Sci. Nov 2018; 11(6): 553-561 Pubmed, Volltext, DOI [6577]
Feng HP. Clin Transl Sci. Nov 2018; 11(6): 562-572 Pubmed, Volltext, DOI [6575]
Feng HP. Clin Transl Sci. Sep 2017; 10(5): 360-365 Pubmed, Volltext, DOI [6572]
Feng HP. J Antimicrob Chemother. Mar 2019; 74(3): 710-717 Pubmed [6574]
Feng HP. J Clin Pharmacol. May 2018; 58(5): 666-673 Pubmed [6578]
Feng J. Front Microbiol. May 2016; 7: 743 Pubmed, Volltext, DOI [7970]
Feng M. J Psychopharmacol. Apr 2017; 31(4): 474-486 Pubmed [5085]
Feng P. Chem Biol Interact. Sep 2018; 293: 115-123 Pubmed [8418]
Feng PF. Mol Pharm. Apr 2019; 16(4): 1477-1488 Pubmed [12705]
Feng X. PLoS One. Jan 2018; 13(1): e0190798 Pubmed, Volltext, DOI [8450]
Feng XQ. J Pain Res. May 2017; 10: 1225-1239 Pubmed, Volltext, DOI [4584]
Feng Z. J Int Med Res. Feb 2013; 41(1): 239-43 Pubmed [7023]
Fenoglio JJ Jr. Hum Pathol. Oct 1981; 12(10): 900-7 Pubmed [2147]
Fenster P. Clin Pharmacol Ther. Apr 1980; 27(4): 450-3 Pubmed [4182]
Fenster PE. Pharmacotherapy. Jan 1986; 6(1): 1-9 Pubmed [13762]
Feret BM. Ann Pharmacother. Apr 2000; 34(4): 483-6 Pubmed [12582]
Fernandes C. Mov Disord. Mar 2011; 26(4): 766-7 Pubmed [9399]
Fernandes E. Int J Mol Sci. Oct 2018; 19(11) Pubmed, Volltext, DOI [8371]
Fernandes FM. PLoS One. Jun 2018; 13(6): e0199028 Pubmed, Volltext, DOI [9610]
Fernandes LC. J Clin Psychopharmacol. Jun 2002; 22(3): 326-9 Pubmed [2805]
Fernandez de Gatta MR. Ther Drug Monit. Jan 1986; 8(4): 416-20 Pubmed [2452]
Fernandez-Abascal J. Int J Mol Sci. Oct 2018; 19(11) Pubmed, Volltext, DOI [10464]
Fernandez-Fernandez B. AIDS Res Treat. Jan 2011; 2011: 354908 Pubmed, Volltext, DOI [5698]
Ferrari A. Pharmacol Res. Dec 2004; 50(6): 551-9 Pubmed [10857]
Ferrari S. Life Sci. Jan 1991; 48(23): 2259-65 Pubmed [5003]
Ferrari SL. Transplantation. Sep 1994; 58(6): 725-7 Pubmed [6042]
Ferraris O. Antiviral Res. Jun 2015; 118: 75-81 Pubmed [8665]
Ferreira F. Eur J Case Rep Intern Med. Jan 2016; 3(2): 000341 Pubmed [11308]
Ferreira JJ. Eur J Neurol. May 2015; 22(5): 815-25, e56 Pubmed [12205]
Ferreira JJ. Lancet Neurol. Feb 2016; 15(2): 154-165 Pubmed [12204]
Ferri N. Pharmacol Res. Sep 2016; 111: 592-599 Pubmed [8515]
Ferro Desideri L. Pharmaceutics. May 2023; 15(5) Pubmed [13350]
Ferry FR. Rev Inst Med Trop Sao Paulo. May 2014; 56(3): 265-6 Pubmed, Volltext, DOI [6446]
Ferry JJ. J Acquir Immune Defic Syndr Hum Retrovirol. Jul 1998; 18(3): 252-9 Pubmed [6906]
Fessel J. Alzheimers Dement (N Y). Nov 2019; 5: 780-788 Pubmed [11451]
Fessler D. Pain Physician. Nov 2012; 15(6): 489-93 Pubmed [6464]
Fetzer J, Kader G, Danaby S. Lithium encephalopathy: a clinical, psychiatric, and EEG evaluation. Am J Psychiatry (1981) 138, 1622-3 [896]
Fezolinetant. Gelbe Liste. Stand May 2024. https://www.gelbe-liste.de/wirkstoffe/Fezolinetant_56955 [13644]
Fichtenbaum CJ. Clin Pharmacokinet. Jan 2002; 41(14): 1195-211 Pubmed [10205]
Fidecka S. Pol J Pharmacol Pharm. Jan 1989; 41(1): 23-32 Pubmed [5167]
Fidecka S. Pol J Pharmacol. Mar 2002; 54(2): 111-7 Pubmed [5327]
Fiehn C. Z Rheumatol. Feb 2021; 80(Suppl 1): 1-9 Pubmed [10832]
Fiets RB. Eur J Hosp Pharm. May 2018; 25(3): 118-122 Pubmed, Volltext, DOI [8477]
Figgitt DP. Drugs. Oct 2000; 60(4): 925-54 Pubmed [10697]
Fightlin RS. J Immunol. Aug 1975; 115(2): 345-50 Pubmed [8384]
Fihlman M. Eur J Clin Pharmacol. Dec 2018; 74(12): 1615-1622 Pubmed [8001]
Fijałkowska-Morawska JB. Ann Transplant. Oct 2011; 16(4): 107-10 Pubmed [7054]
Fila M. Nutrients. Dec 2021; 13(12) Pubmed [11545]
File SE. J Clin Psychopharmacol. Apr 1982; 2(2): 102-6 Pubmed [4787]
Fillastre JP. Antimicrob Agents Chemother. Apr 1994; 38(4): 733-7 Pubmed, Volltext [7248]
Filppula AM. Br J Pharmacol. Apr 2012; 165(8): 2787-98 Pubmed, Volltext, DOI [3469]
Filppula AM. Drug Metab Dispos. Jan 2013; 41(1): 50-9 Pubmed [12100]
Filppula AM. Drug Metab Dispos. Jul 2014; 42(7): 1202-9 Pubmed [4464]
Filteau MJ. Can J Psychiatry. Mar 2000; 45(2): 198-9 Pubmed [2423]
Finch CK. Arch Intern Med. May 2002; 162(9): 985-92 Pubmed [6110]
Finch CK. South Med J. Sep 2002; 95(9): 1099-100 Pubmed [5906]
Finch MB. Br J Clin Pharmacol. Mar 1984; 17(3): 353-5 Pubmed [12938]
Fincham RW. Neurology. Sep 1976; 26(9): 879-81 Pubmed [2112]
Findling O. Neurology. Oct 2008; 71(15): e34-7 Pubmed [5916]
Findling RL. J Child Adolesc Psychopharmacol. Oct 1996; 6(3): 165-75 Pubmed [12493]
Finfgeld DL. J Psychosoc Nurs Ment Health Serv. Feb 2004; 42(2): 16-20 Pubmed [1567]